Identifying the various strengths and limitations of the state-of-the-art imaging systems was at the core of Sunday’s morning session.
At today’s CX Renal Denervation Session Great Debate, delegates voted 3:1 against the motion that renal denervation should be used routinely to treat hypertension. As all of the speakers, regardless of which side of the debate they were, agreed that renal denervation should only be used to treat patients with resistant hypertension, the real focus of the debate centred on what was meant by the word “routine”.
Gerard O Sullivan, Galway, Ireland, spoke in the Venous Challenges sessions on Tuesday 9 April about imaging for iliac deep vein thrombosis and the best modalities to use. He told delegates that computed tomography pulmonary angiography (CTPA) and CT venography are his preferred modalities.
Hypertension affects an estimated 20% to 30% of the world’s adult population. Despite the availability of numerous safe and effective pharmacological therapies, including single pill combinations of two to three drugs, the percentage of patients achieving adequate blood pressure control meeting guideline targets remains low.
Unos investigadores analizaron brebajes del siglo XIX y hallaron que algunos secretos médicos de verdad funcionaban
Vascular anomalies can be broadly classified into vascular tumours (eg. infantile haemangioma) and vascular malformations. The two main categories of vascular malformations are slow-flow (venous, lymphatic and capillary malformations) or fast-flow (arteriovenous malformations and fistulas). The interventional management of vascular malformations is the primary minimally-invasive therapy which largely replaced the surgical approach. The use of accurate terminology to describe this heterogenous, occasionally overlapping group of disorders is crucial for proper management and research. Unfortunately, despite the major improvement in the clinical, genetic and therapeutic management of vascular anomalies, myths and misconceptions about the diagnosis and management of these anomalies continue to be surprisingly pervasive with frequent serious consequences.
An animal study, published ahead of print in the Journal of the American College of Cardiology, indicates that renal denervation delivered through high-intensity focused ultrasound (HIFU) extracorpeal renal denervation may be an alternative approach to managing resistant hypertension as it is associated with blood pressure reduction without significant morbidity or mortality.
Un estudio de Taiwán sugiere que quienes padecen hepatitis C crónica tendrían menos riesgo de desarrollar cáncer hepático si toman fármacos para reducir el colesterol. Esto no prueba que las estatinas previenen el cáncer y un científico ajeno al estudio dice que no hay motivo suficiente para recomendar el uso de esos fármacos para evitar el cáncer de hígado.
Aunque durante una histerectomía también se suelen extirpar los ovarios, un nuevo estudio sugiere que dejarlos intactos sería más beneficioso. Un equipo halló que la extirpación ovárica reducía el riesgo de cáncer de ovario, pero a la vez que potenciaba el riesgo de morir por otras causas más comunes.
The SEATTLE II study, which will investigate the safety and efficacy of ultrasound accelerated thrombolysis with the EkoSonic Endovascular System (EKOS Corporation) for the treatment of massive and submassive pulmonary embolism, has completed enrolment. SEATTLE II is a 150-patient, single-arm prospective study measuring the rapid reduction in right heart strain in a patient population with both massive and submassive pulmonary embolism.
Los procedimientos mínimamente invasivos para operar el corazón y extirpar los fibroides serían más económicos y causarían menos ausencias laborales que las cirugías convencionales.
Un nuevo estudio revela que algunos hospitales implantan filtros en los vasos sanguíneos de más de un tercio de sus pacientes que desarrollan coágulos que podrían llegar a los pulmones, pese a que aún no existen pruebas científicas de que el dispositivo salve vidas.
Vascular Solutions has announced that it has commenced sales of the PolarCath peripheral dilatation system in the United States in collaboration with NuCryo Vascular, the manufacturer of the product.
On 13 March 2013 Boston Scientific announced it is supporting several public education initiatives throughout March to highlight the prevalence and prevention of cancers of the colon and rectum as part of Colorectal Cancer Awareness Month.
Results of the ULTIMA pulmonary embolism trial comparing endovascular therapy to standard of care were presented at the American College of Cardiology meeting in San Francisco, USA, by Nils Kucher, University Hospital, Bern, Switzerland.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos